MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-17-2025
Zynex Market Cap 2011-2026 | ZYXI
As of April 07, 2026 Zynex has a market cap of $ 21.1 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80.8 M | 448 M | 485 M | 268 M | 607 M | 316 M | 125 M | 151 M | 9.13 M | 10 M | 5.47 M | 6.27 M | 10.5 M | 11.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 607 M | 5.47 M | 181 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bruker Corporation
BRKR
|
6.9 K | $ 36.74 | - | $ 5.47 K |  USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 9.38 | - | $ 266 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.59 | - | $ 36.7 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.07 | - | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Delcath Systems
DCTH
|
326 M | $ 9.7 | - | $ 347 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 81.19 | - | $ 47.5 B | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.6 | - | $ 122 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 88.6 | - | $ 12 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.9 | - | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.31 | - | $ 717 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 54.14 | - | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.0 | - | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.63 | - | $ 2.97 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.94 | - | $ 374 M | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.89 | -2.81 % | $ 70.4 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Medtronic PLC
MDT
|
111 B | $ 86.28 | - | $ 111 B | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 171.87 | - | $ 12.9 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.7 | - | $ 29.3 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 32.64 | - | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 11.77 | - | $ 466 M |  Curacao |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Penumbra
PEN
|
13.2 B | $ 329.87 | - | $ 12.8 B | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Insulet Corporation
PODD
|
18.1 B | $ 203.5 | - | $ 14.3 B | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.53 | 0.4 % | $ 7.02 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.13 | -0.24 % | $ 874 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Smith & Nephew plc
SNN
|
29.7 B | $ 32.63 | - | $ 23.8 B |  Britain |
 |
Stryker Corporation
SYK
|
147 B | $ 332.3 | - | $ 127 B | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 24.57 | - | $ 562 M | USA |
 |
TELA Bio
TELA
|
32.4 M | $ 0.63 | 5.47 % | $ 29.6 M | USA |
 |
TransMedics Group
TMDX
|
4.69 B | $ 104.8 | - | $ 3.56 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 19.17 | - | $ 1.3 B | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |